FDA Warns Against Using Chemical Peels Without Professional Supervision
By Physician’s Briefing Staff HealthDay Reporter
THURSDAY, Aug. 1, 2024 -- The U.S. Food and Drug Administration is warning that chemical peels should not be used without the supervision of a dermatologist or other trained professional.
"FDA is warning consumers not to purchase or use certain chemical peel skin products without appropriate professional supervision due to risk of serious skin injuries," the agency said in a news release issued this week.
A dermatologist or licensed and trained practitioner should always be on hand when a peel is being applied. The FDA reminded consumers that it has never approved a chemical peel, and some contain levels of acid so high that they can cause chemical burns.
Nevertheless, many of these products "are sold in beauty product stores and online and marketed for purposes such as acne, discoloration, wrinkles, and collagen production," the agency noted. "They contain ingredients such as trichloroacetic acid (TCA), glycolic acid, salicylic acid, and lactic acid in varying concentrations that are too high to be used safely at home without supervision."
Just how dangerous an unsupervised chemical peel might be depends on how concentrated an acid is used and the number of applications and length of time each is applied.
"These products remove layers of skin to varying depths and may cause severe chemical burns, pain, swelling, infection, skin color changes, and disfiguring scars," the FDA warned. "These injuries may even require emergency care or specialty care from a dermatologist or surgeon."
The FDA has highlighted six different products and has issued warning letters to their respective makers about selling the peels.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted August 2024
Read this next
Narrowband UVB Phototherapy Underused for Pediatric Vitiligo
TUESDAY, April 8, 2025 -- Narrowband UVB (nbUVB) phototherapy may be underutilized in pediatric vitiligo, according to a study published online March 18 in Pediatric...
Air Pollution May Contribute to Skin Health Issues
WEDNESDAY, March 26, 2025 -- Fine particulate matter (PM2.5) appears to be associated with skin redness across age groups, according to a study published online March 12 in PLOS...
American Academy of Dermatology, March 7 to 11
The annual meeting of the American Academy of Dermatology was held from March 7 to 11 in Orlando, Florida, and attracted clinicians, academicians, allied health...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.